| Literature DB >> 29728348 |
Catherine H Mercer1,2, Gwenda Hughes1,3,2, Sonali Wayal1,3,2, David Reid3,2,4, Paula B Blomquist3,2, Peter Weatherburn2,4.
Abstract
BACKGROUND: Sexually transmitted infection (STI) surveillance is vital for tracking the scale and pattern of epidemics; however, it often lacks data on the underlying drivers of STIs.Entities:
Keywords: Web-based survey; electronic health records; feasibility studies; public health surveillance; sexually transmitted diseases
Year: 2018 PMID: 29728348 PMCID: PMC5960042 DOI: 10.2196/publichealth.9010
Source DB: PubMed Journal: JMIR Public Health Surveill ISSN: 2369-2960
Figure 1Study design for developing and implementing the bio-behavioral surveillance tool (BBEST) for sexually transmitted infections. MSM: men who have sex with men; STI: sexually transmitted infection.
Figure 2Survey invitation envelope: back side with a tear-off tab.
Figure 3Screening process to identify participants eligible to complete the Web-based survey. EHR: electronic health records.
Figure 4Feasibility of implementing the Bio-Behavioral Enhanced Surveillance Tool by population of interest. MSM: men who have sex with men.
Figure 5Recruitment cascade among clinics grouped by recruitment success.
Comparison of sociodemographic characteristics of survey participants with all clinic attendees during the study period.
| Sociodemographic characteristics and indicators of sexual health | GUMCAD data on attendees in clinics administering only heterosexual survey (N=97,054) | Survey population in clinics administering only heterosexual survey (N=4184) | |||||
| n (%) | Percentage excluding unknown/missing variables | n (%) | Percentage excluding unknown/missing variables | ||||
| Male | 41,609 (42.87) | 42.87 | 1722 (41.16) | 41.16 | .03 | ||
| Female | 55,411 (57.09) | 57.09 | 2447 (58.48) | 58.48 | .08 | ||
| Trans/othera | Not available | Not available | 15 (0.36) | 0.36 | Not calculated | ||
| Unknown/missing | 34 (0.00) | —b | 0 (0.00) | 0.00 | — | ||
| Gay/bisexual | 9597 (23.06) | 23.90 | 519 (30.14) | 31.52 | <.001 | ||
| Heterosexual | 30,585 (73.51) | 76.10 | 1165 (67.65) | 70.61 | <.001 | ||
| Unknown | 1427 (3.43) | — | 73 (4.24) | — | — | ||
| <25 | 30,034 (30.94) | 30.94 | 1,599 (38.21) | 38.21 | <.001 | ||
| ≥25 | 67,020 (69.05) | 69.05 | 2585 (61.78) | 61.78 | <.001 | ||
| Unknown/missing | 0 (0.00) | — | 0 (0.00) | — | — | ||
| White | 49,409 (50.91) | 56.00 | 2092 (50.00) | 51.20 | <.001 | ||
| Black African | 7960 (8.19) | 9.01 | 418 (9.99) | 10.2 | <.001 | ||
| Black Caribbean | 8368 (8.62) | 9.51 | 640 (15.29) | 15.7 | <.001 | ||
| Black other | 4441 (4.60) | 5.01 | 42 (1.00) | 1.00 | <.001 | ||
| Mixed | 6549 (6.78) | 7.41 | 370 (8.80) | 9.11 | <.001 | ||
| Asian | 8224 (9.29) | 9.29 | 400 (9.62) | 9.81 | .32 | ||
| Other ethnicities | 3288 (3.38) | 3.38 | 125 (2.98) | 2.98 | .25 | ||
| Unknown/missing | 8815 (9.08) | — | 97 (2.31) | — | — | ||
| Yes | 74,217 (76.52) | 76.52 | 2552 (73.98) | 73.98 | <.001 | ||
| No | 22,837 (23.53) | 23.53 | 895 (25.96) | 25.96 | <.001 | ||
| Yes | 14,240 (14.67) | 14.67 | 585 (16.97) | 16.97 | <.001 | ||
| No | 82,814 (85.32) | 85.32 | 2862 (83.03) | 83.03 | <.001 | ||
aTrans not currently recorded on GUMCAD surveillance.
bIndicates "not applicable".
cThere is no “missing” data for these categories as there is no requirement to code when there is no STI screen or STI diagnosis.
dSexual health screen—one of the following test combinations: chlamydia and gonorrhea; chlamydia, gonorrhea, and syphilis; syphilis and HIV; and chlamydia, gonorrhea, syphilis, and HIV.
eSTI: sexually transmitted infections.
fAcute STI—any of chlamydia, gonorrhea, anogenital herpes (first episode), anogenital herpes (first episode), HIV, infectious syphilis, pelvic inflammatory disease/epididymitis, non-specific genital infections, chancroid, lymphogranuloma venereum, donovanosis, trichomoniasis, scabies, pediculosis pubis, molluscum contagiosum, mycoplasma genitalium, shigella, hepatitis A, hepatitis B, and hepatitis C.
Comparison of sociodemographic characteristics of men who have sex with men (MSM) who participated in the survey compared with all MSM attending all the study sites during the study period.
| Sociodemographic characteristics and indicators of sexual health | GUMCAD data (N=11,180) | Survey population (N=751) | |||||
| n (%) | Percentage excluding unknown/missing variables | n (%) | Percentage excluding unknown/missing variables | ||||
| <25 | 1776 (15.88) | 15.88 | 167 (22.2) | 22.2 | <.001 | ||
| ≥25 | 9404 (84.11) | 84.11 | 584 (77.8) | 77.8 | <.001 | ||
| Unknown/missing | 0 (0.00) | 0.00 | 0 (0.0) | 0.0 | —a | ||
| White | 7671 (68.61) | 75.00 | 551 (73.3) | 74.3 | .70 | ||
| Black African | 226 (2.02) | 2.02 | 15 (2.0) | 2.0 | .74 | ||
| Black Caribbean | 350 (3.13) | 3.40 | 37 (4.9) | 5.0 | .03 | ||
| Black other | 132 (1.80) | 1.31 | 2 (0.3) | 0.3 | .02 | ||
| Mixed | 487 (4.35) | 4.80 | 50 (6.7) | 6.7 | .02 | ||
| Asian | 876 (7.83) | 8.61 | 62 (8.3) | 8.3 | .85 | ||
| Other ethnicities | 486 (4.34) | 4.81 | 24 (3.2) | 3.2 | .06 | ||
| Unknown/missing | 952 (8.52) | – | 10 (1.33) | – | – | ||
| Yes | 9051 (80.89) | 80.89 | 406 (71.1) | 71.1 | <.001 | ||
| No | 2129 (19.04) | 19.04 | 165 (28.9) | 28.9 | <.001 | ||
| Yes | 2203 (19.70) | 19.70 | 116 (20.3) | 20.3 | .72 | ||
| No | 8977 (80.29) | 80.29 | 455 (79.7) | 79.7 | .72 | ||
aIndicates "not applicable".
bThere is no “missing” for these categories as there is no requirement to code when there is no STI screen or STI diagnosis.
cSexual health screen—one of the following test combinations: chlamydia and gonorrhea; chlamydia, gonorrhea, and syphilis; syphilis and HIV; and chlamydia, gonorrhea, syphilis, and HIV.
dSTI: sexually transmitted infections.
eAcute STI—any of chlamydia, gonorrhea, anogenital herpes (first episode), anogenital herpes (first episode), HIV, infectious syphilis, pelvic inflammatory disease/epididymitis, nonspecific genital infections, chancroid, lymphogranuloma venereum, donovanosis, trichomoniasis, scabies, pediculosis pubis, molluscum contagiosum, mycoplasma genitalium, shigella, hepatitis A, hepatitis B, and hepatitis C.